Dermoconcept SRL
The score of Dermoconcept shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -3 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Dermoconcept's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −11,846 € | ||||
| Equity | −50,517 € | ||||
| Cash | 25,511 € | ||||
| EBITDA | −11,132 € | ||||
| Total assets | 38,431 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 24 Jan 2026
- Year ended 30 Jun 2024filed on 07 Jan 2025
- Year ended 30 Jun 2023filed on 30 Jan 2024
- Year ended 30 Jun 2022filed on 30 Jan 2023
- Year ended 30 Jun 2021filed on 28 Jan 2022
Dermoconcept's financial analysis
- Solvency-131.4%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dermoconcept
Dermoconcept's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0806.071.780
- VAT number
- BE0806071780
- Peppol
- Registered · 0208:0806071780 · as of 30 Oct 2026
- Legal form
- SRL
- Incorporated
- 01 Sep 2008
- Registered office
- 9000 Ghent
- Latest accounts
- 2025 · filed on 24 Jan 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Dermoconcept (SRL) has been based in Ghent since 2008, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 11,846 € and equity of −50,517 €; its revenue is not published. Its solvency stands at -131.4%, below the median of its sector (44.2%).
Companies similar to Dermoconcept
Companies in the same business, of comparable size and area, outside its group.
- Novafontis Business and other management consultancy activities Liège · balance sheet 85,313 €
- Futurophar Retail sale of pharmaceutical products Ghent · balance sheet 394,606 €
- Styrax Retail sale of pharmaceutical products Merchtem · balance sheet 37,073 €
- SoBayFRo Retail sale of pharmaceutical products Tournai · balance sheet 54,756 €
- Vangheluwe L. Retail sale of pharmaceutical products Ninove · balance sheet 65,040 €
- Sander Koyen Retail sale of pharmaceutical products Wuustwezel · balance sheet 82,286 €
- MBV Consult Retail sale of pharmaceutical products Lier · balance sheet 63,750 €
- Neopharm Retail sale of pharmaceutical products Jette · balance sheet 94,350 €
Frequently asked questions about Dermoconcept
What is the revenue of Dermoconcept?
Dermoconcept files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dermoconcept?
In Belgium, the VAT number is the company number prefixed with BE: BE0806071780 for Dermoconcept, if the company is VAT-registered. Its company number (CBE) is 0806.071.780.
Where is the registered office of Dermoconcept?
According to the CBE register, the registered office of Dermoconcept is in 9000 Ghent.
What is the equity of Dermoconcept?
At the close of the 2025 financial year, the equity of Dermoconcept amounts to -50,517 €, a solvency of -131.4% of total assets.
Who manages Dermoconcept?
The register lists 1 active mandates at Dermoconcept. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dermoconcept
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →